Clinical Trial Update: NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for NP-G2-044 testing as a standalone and in combination in patients with advanced or metastatic solid tumors, currently in Phase 1/Phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Or Metastatic Solid Tumors

Drugs mentioned

• NP-G2-044

Snippet

Sponsor: Novita Pharmaceuticals, Inc. | Conditions: Advanced or Metastatic Solid Tumor Malignancies | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING